Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03196648 · ClinicalTrials.gov registry record · NA

Randomized Trial of a Gum Health Formulation

A NA study, sponsored by Glo Science.

Completed
Registry status
NA
Development phase
39
Enrollment target

NCT03196648 is a NA study that has completed, run by Glo Science. The registered enrollment target is 39 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03196648, a NA study, has completed, sponsored by Glo Science.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the safety and efficacy of a newly formulated foaming gel product on gingivitis and/or moderate periodontitis when used with or without the GLO Science accelerating device (GLO Device), compared to standard tooth brushing with antioxidant whitening toothpaste with or without flossing (split mouth design for control group). This is a 60-day randomized single blinded parallel group study. After 42 days, all use of interventional products were discontinued, and the participants returned to the clinical center at day 60 for final measurements. The primary outcomes assessed in this study were the differences in gingival index (GI) and bleeding on probing (BOP) from baseline to 42 \& 60 days. The secondary outcomes are tooth whitening, oral malodor, pocket depth and plaque amount. It is hypothesized that participants using the gingival health product with the GLO Device will experience greater reductions in GI \& BOP measurements than the control group, as well as participants using the gingival health product on a toothbrush alone.

Interventions

  • OTHER Gingival health formulation in an accelerating device
  • OTHER Gingival health formulation on a toothbrush
  • OTHER OTC fluoride toothpaste

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2015-05-01
Est. Completion 2016-11-30
Phase NA

Sponsor

Glo Science

3 total trials

What the Registry Record Tells You About NCT03196648

The ClinicalTrials.gov registry entry for NCT03196648 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Glo Science, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Gingival health formulation in an accelerating device is the first listed.

NCT03196648 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03196648 about?

NCT03196648 is a clinical study titled "Randomized Trial of a Gum Health Formulation". The purpose of this study is to evaluate the safety and efficacy of a newly formulated foaming gel product on gingivitis and/or moderate periodontitis when used with or without the GLO Science accelerating device (GLO Device), compared to standard tooth brushing with antioxidant whitening toothpaste...

What is the current status of trial NCT03196648?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2015-05-01. Estimated completion is 2016-11-30.

What interventions are being tested in trial NCT03196648?

The interventions under investigation include: Gingival health formulation in an accelerating device (OTHER), Gingival health formulation on a toothbrush (OTHER), OTC fluoride toothpaste (OTHER).

Who is sponsoring clinical trial NCT03196648?

This trial is sponsored by Glo Science, which has 3 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.